[go: up one dir, main page]

PE20030332A1 - Terapia de combinacion para el tratamiento del cancer - Google Patents

Terapia de combinacion para el tratamiento del cancer

Info

Publication number
PE20030332A1
PE20030332A1 PE2002000737A PE2002000737A PE20030332A1 PE 20030332 A1 PE20030332 A1 PE 20030332A1 PE 2002000737 A PE2002000737 A PE 2002000737A PE 2002000737 A PE2002000737 A PE 2002000737A PE 20030332 A1 PE20030332 A1 PE 20030332A1
Authority
PE
Peru
Prior art keywords
alkyl
aryl
alcoxyl
hydroxyl
nr13r14
Prior art date
Application number
PE2002000737A
Other languages
English (en)
Inventor
Julie Cherrington
Jaime Massferrer
Parul Doshi
Original Assignee
Pharmacia Corp
Sugen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp, Sugen Inc filed Critical Pharmacia Corp
Publication of PE20030332A1 publication Critical patent/PE20030332A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A METODOS PARA EL TRATAMIENTO DE CANCER, TRASTORNOS NEOPLASICOS ADMINISTRANDO COMPUESTOS INHIBIDORES DE PROTEINQUINASA, CICLOOXIGENASA-2 DE FORMULA I DONDE R ES H, PIPERAZIN-1-ILMETILO, 4-METILPIPERAZIN-1-ILMETILO, PIPERIDIN-1-ILMETILO, ENTRE OTROS; R1 ES H, HALO, ALQUILO, CICLOALQUILO, ARILO CONR8R9, NR13R14, COR15, (CH2)R16; R2 ES H, HALO, ALQUILO, TRIHALOMETILO, HIDROXILO, ALCOXILO, ENTRE OTROS; R3 ES H, HALOGENO, ALQUILO, TRIHALOMETILO, HIDROXILO, ALCOXILO, ARILO, ENTRE OTROS; R4 ES H, HALOGENO, ALQUILO, HIDROXILO, ALCOXILO, NR13R14, ENTRE OTROS; R5 Y R6 SON H, ALQUILO, COR10; R7 ES H, ALQUILO, ARILO, HETEROARILO, COR17, COR10, ENTRE OTROS; R6 Y R7 FORMAN (CH2)4, (CH2)5, (CH2)6; R8 Y R9 SON H, ALQUILO, ARILO; R10 ES HIDROXILO, ALCOXILO, ARILOXILO, ENTRE OTROS; R11 ES H, ALQUILO; R12 ES NR13R14, OH, COR15, ARILO, HETEROARILO, N(OH)R13; R13 Y R14 SON H, ALQUILO, CIANOALQUILO, ARILO, HETEROARILO; n Y r SON 1-4. SON COMPUESTOS PREFERIDOS ACIDO 6-CLORO-2-TRIFLUOROMETIL-2H-1-BENZOPIRAN-3-CARBOXILICO; ACIDO 6-CLORO-7-METIL-2-TRIFLUOROMETIL-2H-1-BENZOPIRAN-3-CARBOXILICO, ACIDO 8-(1-METILETIL)-2-TRIFLUOROMETIL-2H-1-BENZOPIRAN-3-CARBOXILICO
PE2002000737A 2001-08-15 2002-08-15 Terapia de combinacion para el tratamiento del cancer PE20030332A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31241301P 2001-08-15 2001-08-15

Publications (1)

Publication Number Publication Date
PE20030332A1 true PE20030332A1 (es) 2003-04-05

Family

ID=23211320

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000737A PE20030332A1 (es) 2001-08-15 2002-08-15 Terapia de combinacion para el tratamiento del cancer

Country Status (36)

Country Link
US (1) US7320996B2 (es)
EP (1) EP1427326B1 (es)
JP (1) JP2005501843A (es)
KR (1) KR100656004B1 (es)
CN (1) CN1541098A (es)
AP (1) AP2004002995A0 (es)
AR (1) AR038957A1 (es)
AT (1) ATE414512T1 (es)
AU (1) AU2002329744B2 (es)
BG (1) BG108622A (es)
BR (1) BR0211978A (es)
CA (1) CA2457745A1 (es)
CO (1) CO5560544A2 (es)
CZ (1) CZ2004356A3 (es)
DE (1) DE60229959D1 (es)
EA (1) EA008137B1 (es)
EC (1) ECSP045021A (es)
GE (1) GEP20063868B (es)
HR (1) HRP20040170A2 (es)
HU (1) HUP0500424A3 (es)
IL (1) IL159887A0 (es)
IS (1) IS7137A (es)
MA (1) MA27060A1 (es)
MX (1) MXPA04001464A (es)
NO (1) NO20040516L (es)
NZ (1) NZ530792A (es)
OA (1) OA12651A (es)
PE (1) PE20030332A1 (es)
PL (1) PL368921A1 (es)
RS (1) RS13204A (es)
SK (1) SK1412004A3 (es)
TN (1) TNSN04015A1 (es)
TW (1) TWI230609B (es)
UA (1) UA77002C2 (es)
WO (1) WO2003015608A2 (es)
ZA (1) ZA200400849B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514368A (ja) * 2001-11-21 2005-05-19 スージェン・インコーポレーテッド インドリノン誘導体を含む医薬製剤
ES2292329B2 (es) * 2002-11-27 2009-09-16 Allergan, Inc. Inhibidores de quinasa para el tratamiento de enfermedades.
US6747025B1 (en) 2002-11-27 2004-06-08 Allergan, Inc. Kinase inhibitors for the treatment of disease
CA2510850A1 (en) 2002-12-19 2004-07-08 Pfizer Inc. 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
US7157577B2 (en) * 2003-03-07 2007-01-02 Sugen Inc. 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
MXPA06003929A (es) * 2003-10-08 2006-07-05 Novartis Ag Composicion farmaceutica que comprende acido 5-metil-2-(2'-cloro-6'-fluoroanilino) -fenilacetico.
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
US20060009510A1 (en) * 2004-07-09 2006-01-12 Pharmacia & Upjohn Company Llc Method of synthesizing indolinone compounds
EP1885355A1 (en) * 2005-05-12 2008-02-13 Pfizer, Inc. Anticancer combination therapy using sunitinib malate
WO2007008858A2 (en) * 2005-07-08 2007-01-18 Ford John P Metered-dose and safety and compliance packaging for systemic anticancer therapy
US7928136B2 (en) 2006-09-11 2011-04-19 Curis, Inc. Substituted 2-indolinone as PTK inhibitors containing a zinc binding moiety
US20090004213A1 (en) 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
WO2009030270A1 (en) * 2007-09-03 2009-03-12 Novartis Ag Dihydroindole derivatives useful in parkinson's disease
GB0813873D0 (en) * 2008-07-30 2008-09-03 Univ Dundee Compounds
EP2181991A1 (en) * 2008-10-28 2010-05-05 LEK Pharmaceuticals D.D. Novel salts of sunitinib
EP2186809A1 (en) * 2008-11-13 2010-05-19 LEK Pharmaceuticals D.D. New crystal form of sunitinib malate
WO2012042421A1 (en) 2010-09-29 2012-04-05 Pfizer Inc. Method of treating abnormal cell growth
RU2495628C1 (ru) * 2012-04-18 2013-10-20 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ выбора тактики лечения актинического кератоза
TWI646091B (zh) * 2012-12-28 2019-01-01 日商衛斯克慧特股份有限公司 鹽類及晶形
MX2015011456A (es) * 2013-03-13 2016-05-31 Boston Biomedical Inc Derivados de 3-(arilo o heteroailo) metilenindolino-2-ona como inhibidores de cinasas de la via de las celulas madres cancerosas para el tratamiento del cancer.
CN103923014A (zh) * 2014-05-05 2014-07-16 宁夏宝马药业有限公司 环肌酸制备方法
CA3010848A1 (en) 2016-01-08 2017-07-13 Euclises Pharmaceuticals, Inc. Combination of a chromene compound and a second active agent
CN111759883B (zh) * 2020-07-23 2021-09-17 浙江农林大学 山核桃内果皮提取物在制备抗卵巢癌产品中的应用
CN114853736B (zh) * 2022-07-06 2022-10-21 北京鑫开元医药科技有限公司 具有trk抑制活性的化合物、制备方法、组合物及其用途

Family Cites Families (165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE553661A (es) * 1955-12-23
US3840597A (en) 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
US4002749A (en) * 1975-08-12 1977-01-11 E. R. Squibb & Sons, Inc. Substituted indolinones
US4053613A (en) * 1975-09-17 1977-10-11 E. R. Squibb & Sons, Inc. 1,3,thiazolinyl and 1,3 thiazinyl substituted indolinones
DE2756113A1 (de) 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3310891A1 (de) * 1983-03-25 1984-09-27 Boehringer Mannheim Gmbh, 6800 Mannheim Neue indolinon-(2)-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte
DE3426419A1 (de) * 1984-07-18 1986-01-23 Boehringer Mannheim Gmbh, 6800 Mannheim Neue oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte
DD290192A5 (de) 1986-11-13 1991-05-23 Eisai Co. Ltd,Jp Pyridinderivat mit antiulzeroeser wirkung
JPH0753725B2 (ja) 1987-10-08 1995-06-07 富山化学工業株式会社 ４ｈ―１―ベンゾピラン―４―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
GB8816944D0 (en) * 1988-07-15 1988-08-17 Sobio Lab Compounds
RU2034842C1 (ru) 1989-07-25 1995-05-10 Алкалоида Ведьесети Дьяр Производные хинолина и способ их получения
GB9004483D0 (en) * 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
US5302606A (en) * 1990-04-16 1994-04-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
US5196446A (en) * 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
FR2672596B1 (fr) 1991-02-07 1995-07-13 Roussel Uclaf Nouveaux derives bicycliques azotes, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2676444B1 (fr) 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
GB9115160D0 (en) * 1991-07-12 1991-08-28 Erba Carlo Spa Methylen-oxindole derivatives and process for their preparation
US5124347A (en) * 1991-07-31 1992-06-23 Warner-Lambert Co. 3-5-ditertiarybutylphenyl-4-hydroxymethylidene derivatives of 1,3-dihydro-2H-indole-2-ones as antiinflammatory agents
US5389661A (en) * 1991-12-05 1995-02-14 Warner-Lambert Company Imidazole and 1,2,4-triazole derivatives with angiotensin II antagonist properties
US5322950A (en) * 1991-12-05 1994-06-21 Warner-Lambert Company Imidazole with angiotensin II antagonist properties
FR2694004B1 (fr) * 1992-07-21 1994-08-26 Adir Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
ES2089736T3 (es) 1992-10-28 1996-10-01 Shionogi & Co Derivados de bencilideno.
US5604260A (en) 1992-12-11 1997-02-18 Merck Frosst Canada Inc. 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
GB9226855D0 (en) * 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation
CA2152792C (en) 1993-01-15 2000-02-15 Stephen R. Bertenshaw Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
FR2701260B1 (fr) 1993-02-05 1995-05-05 Esteve Labor Dr Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments.
US5409944A (en) 1993-03-12 1995-04-25 Merck Frosst Canada, Inc. Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
AU6575094A (en) 1993-04-27 1994-11-21 Wellcome Foundation Limited, The Cyclooxygenase and 5-lipoxygenase inhibiting n(3-biphenylyl-1(s)-methyl-2-propenyl) acetohydroxamic acid derivatives
AU6718494A (en) 1993-05-13 1994-12-12 Merck Frosst Canada Inc. 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase
US5380738A (en) 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US5436265A (en) 1993-11-12 1995-07-25 Merck Frosst Canada, Inc. 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5344991A (en) 1993-10-29 1994-09-06 G.D. Searle & Co. 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
RO118291B1 (ro) 1993-11-30 2003-04-30 Searle & Co Derivati de pirazol 1,3,4,5 - tetrasubstituiti si compozitie farmaceutica care ii contine
US5475018A (en) 1993-11-30 1995-12-12 G. D. Searle & Co. 1,5-diphenyl pyrazole compounds for treatment of inflammation
US5466823A (en) 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
ES2133740T3 (es) 1994-02-10 1999-09-16 Searle & Co Espiro-compuestos sustituidos para el tratamiento de la inflamacion.
US5418254A (en) 1994-05-04 1995-05-23 G. D. Searle & Co. Substituted cyclopentadienyl compounds for the treatment of inflammation
WO1995030652A1 (en) 1994-05-04 1995-11-16 G.D. Searle & Co. Substituted spirodienes for the treatment of inflammation
US5486534A (en) 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
WO1996003392A1 (en) 1994-07-27 1996-02-08 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation
US5616601A (en) 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US5620999A (en) 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
RU2128175C1 (ru) 1994-08-09 1999-03-27 Эйсай Ко., Лтд. Конденсированный пиридазин или его фармакологически приемлемая соль, средство, проявляющее ингибирующую активность в отношении циклической гмф- фосфодиэстеразы
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5547975A (en) 1994-09-20 1996-08-20 Talley; John J. Benzopyranopyrazolyl derivatives for the treatment of inflammation
GB2294879A (en) 1994-10-19 1996-05-15 Merck & Co Inc Cylcooxygenase-2 Inhibitors
EP0788476B1 (en) 1994-10-27 1999-10-20 Merck Frosst Canada & Co. Stilbene derivatives useful as cyclooxygenase-2 inhibitors
US5739166A (en) 1994-11-29 1998-04-14 G.D. Searle & Co. Substituted terphenyl compounds for the treatment of inflammation
JP3181190B2 (ja) 1994-12-20 2001-07-03 日本たばこ産業株式会社 オキサゾール誘導体
JP2636819B2 (ja) 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
ES2191069T3 (es) 1994-12-21 2003-09-01 Merck Frosst Canada Inc Diaril-2-(5h)-furanonas como inhibidores de cox-2.
US5552422A (en) 1995-01-11 1996-09-03 Merck Frosst Canada, Inc. Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
WO1996023786A1 (en) 1995-01-31 1996-08-08 Merck Frosst Canada Inc. 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
US5596008A (en) 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
US5686470A (en) 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation
JP3267300B2 (ja) 1995-02-13 2002-03-18 ジー．ディー．サール アンド カンパニー 炎症の治療のための置換イソオキサゾール
US5633272A (en) 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
KR19980702372A (ko) 1995-02-21 1998-07-15 구니이 야쓰오 글루타민산 수용체 작용약
KR19980703559A (ko) 1995-04-04 1998-11-05 그레이엄브레레톤 이미다조［1,2-ａ］피리딘 유도체
GB9507298D0 (en) * 1995-04-07 1995-05-31 Pharmacia Spa Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors
US5691374A (en) 1995-05-18 1997-11-25 Merck Frosst Canada Inc. Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
JPH11509835A (ja) 1995-05-19 1999-08-31 ジー．ディー．サール アンド カンパニー 炎症を治療するための置換オキサゾール
US5510368A (en) 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs
US5639780A (en) 1995-05-22 1997-06-17 Merck Frosst Canada, Inc. N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
WO1996038418A1 (en) 1995-06-02 1996-12-05 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5643933A (en) 1995-06-02 1997-07-01 G. D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
US5700816A (en) 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
US6342510B1 (en) 1995-06-12 2002-01-29 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist
WO1996041626A1 (en) 1995-06-12 1996-12-27 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
CA2180624C (en) 1995-07-12 2006-12-12 Cheuk Kun Lau Diphenyl-1,2,3-thiadiazoles as anti-inflammatory agents
GB9514518D0 (en) 1995-07-15 1995-09-13 Sod Conseils Rech Applic Guanidine salt inhibitors of NO synthase and cyclooxygenase
US5968974A (en) 1995-07-19 1999-10-19 Merck & Co., Inc. Method of treating colonic adenomas
CZ294516B6 (cs) 1995-07-19 2005-01-12 Merck And Co., Inc. Farmaceutický prostředek
EP0853481A1 (en) 1995-09-27 1998-07-22 Merck Frosst Canada Inc. Compositions for treating inflammation containing certain prostaglandins and a selective cyclooxygenase-2 inhibitor
GB9520584D0 (en) 1995-10-09 1995-12-13 Fujisawa Pharmaceutical Co Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
UA57002C2 (uk) 1995-10-13 2003-06-16 Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування
US6376733B1 (en) 1996-01-25 2002-04-23 Exxonmobil Chemical Patents Inc. Process for production of paraxylene
ATE198323T1 (de) 1996-02-01 2001-01-15 Merck Frosst Canada Inc Diphenylstibene als prodrugs zu cox-2-inhibitoren
WO1997028121A1 (en) 1996-02-01 1997-08-07 Merck Frosst Canada Inc. Alkylated styrenes as prodrugs to cox-2 inhibitors
US5733909A (en) 1996-02-01 1998-03-31 Merck Frosst Canada, Inc. Diphenyl stilbenes as prodrugs to COX-2 inhibitors
PT880363E (pt) 1996-02-13 2002-12-31 Searle & Co Combinacoes com efeitos imunossupressores cntendo um inibidor da ciclooxigenase-2 e um inibidor da hidrolase do leucotrieno a4
AU1850597A (en) 1996-02-13 1997-09-02 G.D. Searle & Co. Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors
EP0880362B1 (en) 1996-02-13 2005-05-25 G.D. SEARLE & CO. Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
WO1997036863A1 (en) 1996-03-29 1997-10-09 Merck Frosst Canada Inc. Bisarylcyclobutene derivates as cyclooxygenase inhibitors
CN1159019C (zh) 1996-04-02 2004-07-28 火星有限公司 可提取物化合物以及其制备方法和用途
FR2747123B1 (fr) 1996-04-04 1998-06-26 Union Pharma Scient Appl Nouveaux derives diarylmethylidene tetrahydrofurane, leurs procedes de preparation, et leurs utilisations en therapeutique
US6180651B1 (en) 1996-04-04 2001-01-30 Bristol-Myers Squibb Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics
US5908858A (en) 1996-04-05 1999-06-01 Sankyo Company, Limited 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
PT1288206E (pt) 1996-04-12 2008-11-14 Searle Llc Derivados de benzenossulfonamida substituídos como pró-fármacos de inibidores de cox-2
JP2000509032A (ja) 1996-04-23 2000-07-18 メルク フロスト カナダ アンド カンパニー 選択的シクロオキシゲナーゼ―２阻害剤としてのピリジニル―２―シクロペンテン―１―オン
ATE299888T1 (de) * 1996-05-03 2005-08-15 Abbott Lab Antiangiogenische peptiden, dafür kodierende polynukleotide und verfahren zur hemmung der angiogenesis
CA2254121A1 (en) 1996-05-17 1997-11-27 Bruno Hancock Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
AU717602B2 (en) 1996-05-30 2000-03-30 F. Hoffmann-La Roche Ag Novel pyrrole derivatives
US5677318A (en) 1996-07-11 1997-10-14 Merck Frosst Canada, Inc. Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents
ATE249437T1 (de) 1996-07-18 2003-09-15 Merck Frosst Canada Inc Substituierte pyridine als selektive cyclooxygenase inhibitoren
CN1230948A (zh) 1996-07-26 1999-10-06 美国家用产品公司 吡喃并吲哚和咔唑cox－2抑制剂
US5776967A (en) 1996-07-26 1998-07-07 American Home Products Corporation Pyranoindole inhibitors of COX--2
FR2751964B1 (fr) 1996-08-01 1998-10-30 Union Pharma Scient Appl Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation, et leurs utilisations en therapeutique
FR2751966B1 (fr) 1996-08-01 1998-10-30 Union Pharma Scient Appl Nouveaux derives 1,2-diarylindoles, leurs procedes de preparation, et leurs utilisations en therapeutique
WO1998006715A1 (en) 1996-08-09 1998-02-19 Smithkline Beecham Corporation Novel piperazine containing compounds
EA003754B1 (ru) 1996-08-14 2003-08-28 Джи. Ди. Сирл Энд Ко. 4-[5-метил-3-фенилизоксазол-4-ил] бензолсульфонамид
US5830911A (en) 1996-08-14 1998-11-03 American Home Products Corporation Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
EP0956018A4 (en) 1996-08-21 2000-01-12 Smithkline Beecham Corp IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE
FR2753449B1 (fr) 1996-09-13 1998-12-04 Union Pharma Scient Appl Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
FR2754256B1 (fr) 1996-10-08 1998-12-24 Union Pharma Scient Appl Nouveaux derives 1,2-diarylmethylenes, leurs procedes de preparation, et leurs utilisations en therapeutique
RO120172B1 (ro) 1996-10-15 2005-10-28 G.D. Searle & Co. Utilizarea unui compus inhibitor de ciclooxigenază-2, în tratamentul şi/sau prevenirea neoplaziei
US5681842A (en) 1996-11-08 1997-10-28 Abbott Laboratories Prostaglandin synthase-2 inhibitors
US5869524A (en) 1996-11-12 1999-02-09 American Home Products Corporation Indene inhibitors of COX-2
CA2269035A1 (en) 1996-11-12 1998-05-22 American Home Products Corporation Indene inhibitors of cox-2
US5777791A (en) 1996-11-26 1998-07-07 Minnesota Mining And Manufacturing Company Wet retroreflective pavement marking articles
JPH10158234A (ja) 1996-12-02 1998-06-16 Kotobuki Seiyaku Kk ２−フェニルアズレン誘導体及びその製造方法
ATE257825T1 (de) 1996-12-09 2004-01-15 Pfizer Benzimidazol-verbindungen
ES2208964T3 (es) 1996-12-10 2004-06-16 G.D. SEARLE & CO. Compuestos de pirrolilo substituidos para el tratamiento de la inflamacion.
JP4167733B2 (ja) 1996-12-16 2008-10-22 花王株式会社 ＮＦ−κＢ活性化抑制剤
US5973191A (en) 1996-12-30 1999-10-26 Vanderbilt University Selective inhibitors of prostaglandin endoperoxide synthase-2
WO1998037235A1 (en) 1997-02-24 1998-08-27 Cornell Research Foundation, Inc. Method of screening agents as candidates for drugs or sources of drugs
EP0863134A1 (en) 1997-03-07 1998-09-09 Merck Frosst Canada Inc. 2-(3,5-difluorophenyl)-3-(4-(methyl-sulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cyclooxygenase-2
ATE244232T1 (de) 1997-03-14 2003-07-15 Merck Frosst Canada Inc (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer
CA2283399C (en) 1997-03-14 2006-02-21 Merck Frosst Canada & Co. Pyridazinones as inhibitors of cyclooxygenase-2
FI971124A0 (fi) 1997-03-18 1997-03-18 Locus Genex Oy Metod foer diagnostisering av magcancer
AU6818298A (en) 1997-04-02 1998-10-22 Merck Frosst Canada & Co. Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors
SE9701304D0 (sv) 1997-04-09 1997-04-09 Astra Pharma Prod Compounds
TW492959B (en) 1997-04-18 2002-07-01 Merck & Co Inc Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6034256A (en) 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
EP1001764A4 (en) 1997-05-29 2005-08-24 Merck & Co Inc Heterocyclic amides as cell adhesion inhibitors
WO1998053817A1 (en) 1997-05-29 1998-12-03 Merck & Co., Inc. Biarylalkanoic acids as cell adhesion inhibitors
EP0994870A4 (en) 1997-06-19 2002-10-23 Smithkline Beecham NEW IMIDAZOLE COMPOUNDS SUBSTITUTED BY AN ARYLOXYREST
SE9702534D0 (sv) 1997-07-01 1997-07-01 Astra Pharma Prod Compounds
AR016294A1 (es) 1997-07-02 2001-07-04 Smithkline Beecham Corp Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
US6251914B1 (en) 1997-07-02 2001-06-26 Smithkline Beecham Corporation Cycloalkyl substituted imidazoles
AP9801302A0 (en) 1997-07-23 2000-01-23 Pfizer Indole compounds as anti-inflammatory/analgesic agents..
CA2294548A1 (en) 1997-08-22 1999-03-04 Abbott Laboratories Pyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
WO1999010331A1 (en) 1997-08-22 1999-03-04 Abbott Laboratories Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
AU750125B2 (en) 1997-08-27 2002-07-11 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
CO4960662A1 (es) 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
US6451794B1 (en) 1997-09-05 2002-09-17 Smithkline Beecham Corporation 2,3-Diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2(COX-2) inhibitors
JP4368524B2 (ja) 1997-09-12 2009-11-18 メルク フロスト カナダ リミテツド シクロオキシゲナーゼ−２阻害薬としての２−アミノピリジン類
ES2131015B1 (es) 1997-09-12 2000-03-01 Almirall Prodesfarma Sa Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
WO1999014194A1 (en) 1997-09-12 1999-03-25 Merck Frosst Canada & Co. 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
RS49982B (sr) 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
AUPO941497A0 (en) 1997-09-24 1997-10-16 Fujisawa Pharmaceutical Co., Ltd. Novel compounds
AR015938A1 (es) 1997-09-25 2001-05-30 Merck Sharp & Dohme Procedimiento para preparar diaril piridinas utiles como inhibidores cox-2 y compuesto intermediario
US6133305A (en) * 1997-09-26 2000-10-17 Sugen, Inc. 3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
FR2769311B1 (fr) 1997-10-07 1999-12-24 Union Pharma Scient Appl Nouveaux derives 3,4-diarylthiazolin-2-one ou -2-thione, leurs procedes de preparation et leurs utilisations en therapeutique
SE9703693D0 (sv) 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination
US5972986A (en) * 1997-10-14 1999-10-26 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
FR2770131A1 (fr) 1997-10-27 1999-04-30 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
GB2330833A (en) 1997-10-29 1999-05-05 Merck & Co Inc PREPARATION OF 4-(4-Methylsulfonylphenyl)-2-furanones USEFUL AS COX-2 INHIBITORS
AU741790B2 (en) 1997-10-30 2001-12-06 Merck Frosst Canada & Co. Diaryl-5-alkyl-5-methyl-2(5H)-furanones as selective cyclooxygenase-2 inhibitors
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
AUPP042397A0 (en) 1997-11-18 1997-12-11 Fujisawa Pharmaceutical Co., Ltd. 5-arylpyrazole compounds
FR2771005B1 (fr) 1997-11-18 2002-06-07 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
FR2771412B1 (fr) 1997-11-26 2000-04-28 Adir Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69835832T2 (de) 1997-12-16 2007-04-05 Johnson & Johnson Consumer Companies, Inc. Zusammensetzungen und methoden zur regulierung der phagozytose und icam-1 expression
WO1999030721A1 (en) 1997-12-17 1999-06-24 Cornell Research Foundation, Inc. Cyclooxygenase-2 inhibition
JP4528440B2 (ja) 1998-05-29 2010-08-18 スージェン， インク． ピロール置換２−インドリノンタンパク質キナーゼ阻害剤
KR20010108063A (ko) * 1998-12-31 2001-12-07 수젠, 인크. 단백질 인산화 효소의 조절 및 암의 화학적 치료를 위한3-헤테로아릴리데닐-2-인돌리논 화합물
NZ519697A (en) * 1999-12-22 2004-08-27 Sugen Inc Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds
EP1259234B9 (en) * 1999-12-30 2007-02-14 Sugen, Inc. 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
SK287142B6 (sk) * 2000-02-15 2010-01-07 Sugen, Inc. Inhibítory proteínkináz na báze pyrolom substituovaného 2-indolinónu, farmaceutický prípravok s ich obsahom a ich použitie
ES2290120T3 (es) * 2000-03-17 2008-02-16 Avocet Polymer Technologies, Inc. Procedimientos para mejorar la dimension y el aspecto de una herida.

Also Published As

Publication number Publication date
MXPA04001464A (es) 2005-02-17
CA2457745A1 (en) 2003-02-27
NO20040516L (no) 2004-04-13
DE60229959D1 (de) 2009-01-02
CN1541098A (zh) 2004-10-27
IL159887A0 (en) 2004-06-20
WO2003015608A2 (en) 2003-02-27
PL368921A1 (en) 2005-04-04
MA27060A1 (fr) 2004-12-20
EP1427326B1 (en) 2008-11-19
GEP20063868B (en) 2006-07-10
ZA200400849B (en) 2005-05-03
HUP0500424A3 (en) 2008-04-28
US20030216410A1 (en) 2003-11-20
NZ530792A (en) 2005-09-30
HUP0500424A2 (en) 2007-02-28
BG108622A (bg) 2005-10-31
UA77002C2 (en) 2006-10-16
IS7137A (is) 2004-01-30
KR20040043193A (ko) 2004-05-22
RS13204A (en) 2007-02-05
TWI230609B (en) 2005-04-11
WO2003015608A3 (en) 2003-10-30
AR038957A1 (es) 2005-02-02
SK1412004A3 (en) 2004-10-05
EA200400235A1 (ru) 2004-10-28
US7320996B2 (en) 2008-01-22
JP2005501843A (ja) 2005-01-20
EA008137B1 (ru) 2007-04-27
KR100656004B1 (ko) 2007-02-28
BR0211978A (pt) 2004-07-20
ATE414512T1 (de) 2008-12-15
EP1427326A4 (en) 2005-06-08
OA12651A (en) 2006-06-15
CZ2004356A3 (cs) 2004-12-15
TNSN04015A1 (en) 2006-06-01
CO5560544A2 (es) 2005-09-30
AP2004002995A0 (en) 2004-03-31
ECSP045021A (es) 2004-04-28
EP1427326A2 (en) 2004-06-16
HRP20040170A2 (en) 2004-08-31
AU2002329744B2 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
PE20030332A1 (es) Terapia de combinacion para el tratamiento del cancer
NZ795045A (en) Compound for the treatment of braf-associated diseases and disorders
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
RU2009125578A (ru) Новые замещенные диазаспиропиридиноновые производные для применения в лечении мсн-1-опосредованных заболеваний
TW200732339A (en) Nitrogen-containing bicyclic heteroaryl compounds and methods of use
TNSN03144A1 (en) Pyrrolopyrimidines as protein kinase inhibitors
NO20044475L (no) 2-(2,6-diklorfenyl)-diarulimidazoler
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
MXPA04005886A (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
EA200870360A1 (ru) Бензимидазолы, обладающие активностью в отношении рецепторов м1, и их применение в медицине
SE0104332D0 (sv) Therapeutic agents
DE50310516D1 (de) Fredericamycin-derivate
BR0206633A (pt) Derivados de 1-aril- ou 1-arilsulfonilbenzazol como ligandos de 5-hidroxitriptamina-6
TW200504034A (en) Therapeutic agents
TW200503712A (en) (2-carboxamido)(3-amino)thiophene compounds
DE60216745D1 (de) Carbolin Derivate als Hemmstoffe von Phospphodiesterase 5 (PDE5) zur Behandlung kardiovaskulärer Erkrankungen und der erektilen Dysfunktion
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
RU2003137007A (ru) Новые пиридилцианогуанидиновые соединения
MXPA05014201A (es) Pirazolo [3,4-b] piridin-6-onas como inhibidores de la gsk-3.
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
MXPA06000701A (es) Compuestos de sulfonildihidrobencimidazolona como ligandos de 5-hidroxitriptamina-6.
TW200509933A (en) Therapeutic agents

Legal Events

Date Code Title Description
FC Refusal